Σεπ162015Βιβλιογραφικά δεδομέναΓια να δείτε το άρθρο πιέστε εδώ Κατηγορία Βιβλιογραφικά δεδομένα16 Σεπτεμβρίου 2015 Μοιραστείτε το! Share on FacebookShare on Facebook Share on XShare on X Share on LinkedInShare on LinkedIn Share on WhatsAppShare on WhatsApp Post navigationΠροηγούμενοPrevious post:Long-term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: A cohort study of 53,500 subjects.ΕπόμενοNext post:Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses.Σχετικά ΆρθραPhase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection17 Ιουνίου 2026Physical frailty is the most important predictor of early mortality in hospitalized patients with decompensated cirrhosis15 Ιουνίου 2026Liver transplantation is the major determinant of > 10-year survival in patients with hepatocellular carcinoma14 Μαΐου 2026Geographic disparities in hepatitis B vaccine coverage across Africa: Implications for targeted interventions and 2030 goals8 Μαΐου 2026Consensus statements of the Hellenic Autoimmune Liver Diseases Study Group on the diagnosis and current management of primary biliary cholangitis6 Μαΐου 2026Risk of de novo HCC in patients with MASLD following direct-acting antiviral – induced cure of HCV infection24 Απριλίου 2026
Physical frailty is the most important predictor of early mortality in hospitalized patients with decompensated cirrhosis15 Ιουνίου 2026
Liver transplantation is the major determinant of > 10-year survival in patients with hepatocellular carcinoma14 Μαΐου 2026
Geographic disparities in hepatitis B vaccine coverage across Africa: Implications for targeted interventions and 2030 goals8 Μαΐου 2026
Consensus statements of the Hellenic Autoimmune Liver Diseases Study Group on the diagnosis and current management of primary biliary cholangitis6 Μαΐου 2026
Risk of de novo HCC in patients with MASLD following direct-acting antiviral – induced cure of HCV infection24 Απριλίου 2026
